|
1
|
Ewing I, Hurley JJ, Josephides E and
Millar A: The molecular genetics of colorectal cancer. Frontline
Gastroenterol. 5:26–30. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fearon ER and Vogelstein B: A genetic
model for colorectal tumorigenesis. Cell. 61:759–767. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yeung AT, Patel BB, Li XM, Seeholzer SH,
Coudry RA, Cooper HS, Bellacosa A, Boman BM, Zhang T, Litwin S,
Ross EA, Conrad P, Crowell JA, Kopelovich L and Knudson A: One-hit
effects in cancer: altered proteome of morphologically normal colon
crypts in familial adenomatous polyposis. Cancer Res. 68:7579–7586.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Phelps RA, Chidester S, Dehghanizadeh S,
Phelps J, Sandoval IT, Rai K, Broadbent T, Sarkar S, Burt RW and
Jones DA: A two-step model for colon adenoma initiation and
progression caused by APC loss. Cell. 137:623–634. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sideris M and Papagrigoriadis S: Molecular
biomarkers and classification models in the evaluation of the
prognosis of colorectal cancer. Anticancer Res. 34:2061–2068.
2014.PubMed/NCBI
|
|
7
|
Fearon ER: Molecular genetics of
colorectal cancer. Annu Rev Pathol. 6:479–507. 2011. View Article : Google Scholar
|
|
8
|
Moon RT, Kohn AD, De Ferrari GV and Kaykas
A: WNT and beta-catenin signalling: diseases and therapies. Nat Rev
Genet. 5:691–701. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
McCubrey JA, Steelman LS, Bertrand FE,
Davis NM, Sokolosky M, Abrams SL, Montalto G, D’Assoro AB, Libra M,
Nicoletti F, Maestro R, Basecke J, Rakus D, Gizak A, Demidenko ZN,
Cocco L, Martelli AM and Cervello M: GSK-3 as potential target for
therapeutic intervention in cancer. Oncotarget. 5:2881–2911.
2014.PubMed/NCBI
|
|
10
|
Hoesel B and Schmid JA: The complexity of
NF-κB signaling in inflammation and cancer. Mol Cancer. 12:862013.
View Article : Google Scholar
|
|
11
|
Li H, Huang K, Liu X, Liu J, Lu X, Tao K,
Wang G and Wang J: Lithium chloride suppresses colorectal cancer
cell survival and proliferation through ROS/GSK-3β/NF-κB signaling
pathway. Oxid Med Cell Longev. 2014:2418642014. View Article : Google Scholar
|
|
12
|
Mishra R: Glycogen synthase kinase 3 beta:
can it be a target for oral cancer. Mol Cancer. 9:1442010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Loboda A, Nebozhyn MV, Watters JW, Buser
CA, Shaw PM, Huang PS, Van’t Veer L, Tollenaar RA, Jackson DB,
Agrawal D, Dai H and Yeatman TJ: EMT is the dominant program in
human colon cancer. BMC Med Genomics. 4:92011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Batlle E, Sancho E, Francí C, Domínguez D,
Monfar M, Baulida J and García De Herreros A: The transcription
factor snail is a repressor of E-cadherin gene expression in
epithelial tumor cells. Nat Cell Biol. 2:84–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cano A, Pérez-Moreno MA, Rodrigo I,
Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The
transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kreso A and O’Brien CA: Colon cancer stem
cells. Curr Protoc Stem Cell Biol. Chapter 3(Unit 3):
12008.PubMed/NCBI
|
|
18
|
Liehr T, Weise A, Heller A, Starke H,
Mrasek K, Kuechler A, Weier HU and Claussen U: Multicolor
chromosome banding (MCB) with YAC/BAC-based probes and
region-specific micro-dissection DNA libraries. Cytogenet Genome
Res. 97:43–50. 2002. View Article : Google Scholar
|
|
19
|
Duraturo F, Cavallo A, Liccardo R, Cudia
B, De Rosa M, Diana G and Izzo P: Contribution of large genomic
rearrangements in Italian Lynch syndrome patients: characterization
of a novel alu-mediated deletion. Biomed Res Int. 2013:2198972013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Galatola M, Miele E, Strisciuglio C,
Paparo L, Rega D, Delrio P, Duraturo F, Martinelli M, Rossi GB,
Staiano A, Izzo P and De Rosa M: Synergistic effect of
interleukin-10-receptor variants in a case of early-onset
ulcerative colitis. World J Gastroenterol. 19:8659–8670. 2013.
View Article : Google Scholar :
|
|
21
|
Galatola M, Paparo L, Duraturo F, Turano
M, Rossi GB, Izzo P and De Rosa M: Beta catenin and cytokine
pathway dysregulation in patients with manifestations of the ‘PTEN
hamartoma tumor syndrome’. BMC Med Genet. 13:282012. View Article : Google Scholar
|
|
22
|
Shaffer LG, McGowan-Jordan J and Schmid M:
ISCN 2013: An International System for Human Cytogenetic
Nomenclature. 1st edition. S. Karger AG; Basel: pp. 1402013
|
|
23
|
Alberici P and Fodde R: The role of the
APC tumor suppressor in chromosomal instability. Genome Dyn.
1:149–170. 2006. View Article : Google Scholar
|
|
24
|
Sameer AS, Nissar S and Fatima K: Mismatch
repair pathway: molecules, functions, and role in colorectal
carcinogenesis. Eur J Cancer Prev. 23:246–257. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Therkildsen C, Jönsson G,
Dominguez-Valentin M, Nissen A, Rambech E, Halvarsson B, Bernstein
I, Borg K and Nilbert M: Gain of chromosomal region 20q and loss of
18 discriminates between Lynch syndrome and familial colorectal
cancer. Eur J Cancer. 49:1226–1235. 2013. View Article : Google Scholar
|
|
26
|
Castellví-Bel S, Castells A, Johnstone CN,
Piñol V, Pellisé M, Elizalde JI, Romo N, Rustgi AK and Piqué JM:
Evaluation of PARVG located on 22q13 as a candidate tumor
suppressor gene for colorectal and breast cancer. Cancer Genet
Cytogenet. 144:80–82. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zheng HT, Peng ZH, Zhou CZ, Li DP, Wang
ZW, Qiu GQ and He L: Detailed deletion mapping of loss of
heterozygosity on 22q13 in sporadic colorectal cancer. World J
Gastroenterol. 11:1668–1672. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li X, Pei D and Zheng H: Transitions
between epithelial and mesenchymal states during cell fate
conversions. Protein Cell. 5:580–591. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell
LL, Polyak K, Brisken C, Yang J and Weinberg RA: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jope RS: Lithium and GSK-3: one inhibitor,
two inhibitory actions, multiple outcomes. Trends Pharmacol Sci.
24:441–443. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Elzagheid A, Emaetig F, Alkikhia L,
Buhmeida A, Syrjänen K, El-Faitori O, Latto M, Collan Y and
Pyrhönen S: High cyclooxygenase-2 expression is associated with
advanced stages in colorectal cancer. Anticancer Res. 33:3137–3143.
2013.PubMed/NCBI
|
|
32
|
Beurel E and Jope RS: The paradoxical pro-
and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic
apoptosis signaling pathways. Prog Neurobiol. 79:173–189. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shakoori A, Ougolkov A, Yu ZW, Zhang B,
Modarressi MH, Billadeau DD, Mai M, Takahashi Y and Minamoto T:
Deregulated GSK3beta activity in colorectal cancer: its association
with tumor cell survival and proliferation. Biochem Biophys Res
Commun. 334:1365–1373. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shakoori A, Mai W, Miyashita K, Yasumoto
K, Takahashi Y, Ooi A, Kawakami K and Minamoto T: Inhibition of
GSK-3 beta activity attenuates proliferation of human colon cancer
cells in rodents. Cancer Sci. 98:1388–1393. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Du Q and Geller DA: Cross-regulation
between Wnt and NF-κB signaling pathways. For Immunopathol Dis
Therap. 1:155–181. 2010. View Article : Google Scholar
|
|
36
|
Katoh M and Katoh M: Transcriptional
mechanisms of WNT5A based on NF-κB, Hedgehog, TGFβ, and Notch
signaling cascades. Int J Mol Med. 23:763–769. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Conacci-Sorrell M, Zhurinsky J and
Ben-Ze’ev A: The cadherin-catenin adhesion system in signaling and
cancer. J Clin Invest. 109:987–991. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Solanas G, Porta-de-la-Riva M, Agusti C,
Casagolda D, Sánchez-Aguilera F, Larriba MJ, Pons F, Peiró S,
Escrivà M, Muñoz A, Duñach M, de Herreros AG and Baulida J:
E-cadherin controls beta-catenin and NF-kappaB transcriptional
activity in mesenchymal gene expression. J Cell Sci. 121:2224–2234.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Benoit YD, Guezguez B, Boyd AL and Bhatia
M: Molecular Pathways: Epigenetic modulation of wnt/glycogen
synthase kinase-3 signaling to target human cancer stem cells. Clin
Cancer Res. 20:5372–5378. 2014. View Article : Google Scholar : PubMed/NCBI
|
